CNA Financial’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28,451
| Closed | -$273K | – | 92 |
|
|
2022
Q3 | $273K | Sell |
28,451
-510
| -2% | -$4.89K | 0.1% | 146 |
|
|
2022
Q2 | $210K | Sell |
28,961
-230
| -0.8% | -$1.67K | 0.07% | 166 |
|
|
2022
Q1 | $377K | Sell |
29,191
-110
| -0.4% | -$1.42K | 0.12% | 163 |
|
|
2021
Q4 | $468K | Buy |
29,301
+3,140
| +12% | +$50.2K | 0.12% | 164 |
|
|
2021
Q3 | $420K | Buy |
26,161
+1,080
| +4% | +$17.3K | 0.11% | 171 |
|
|
2021
Q2 | $347K | Buy |
25,081
+140
| +0.6% | +$1.94K | 0.1% | 183 |
|
|
2021
Q1 | $364K | Sell |
24,941
-3,199
| -11% | -$46.7K | 0.11% | 180 |
|
|
2020
Q4 | $489K | Buy |
28,140
+3,250
| +13% | +$56.5K | 0.15% | 160 |
|
|
2020
Q3 | $456K | Buy |
24,890
+2,810
| +13% | +$51.5K | 0.17% | 139 |
|
|
2020
Q2 | $394K | Buy |
+22,080
| New | +$394K | 0.16% | 150 |
|